ADC Therapeutics
ADCT
ADCT
105 hedge funds and large institutions have $271M invested in ADC Therapeutics in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
8.22% less ownership
Funds ownership: 68.52% → 60.3% (-8.2%)
56% less call options, than puts
Call options by funds: $161K | Put options by funds: $364K
Holders
105
Holding in Top 10
4
Calls
$161K
Puts
$364K
Top Buyers
| 1 | +$4.38M | |
| 2 | +$4.18M | |
| 3 | +$2.5M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.15M |
| 5 |
Morgan Stanley
New York
|
+$1.97M |
Top Sellers
| 1 | -$9.44M | |
| 2 | -$7.9M | |
| 3 | -$2.64M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.26M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.78M |
